• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell . Respiratory viral infections prime accelerated lung cancer growth

tetano

Editor, Senior Moderator
Cell


. 2026 Mar 11:S0092-8674(26)00220-5.
doi: 10.1016/j.cell.2026.02.013. Online ahead of print.
Respiratory viral infections prime accelerated lung cancer growth

Wei Qian[SUP] 1 [/SUP], Xiaoqin Wei[SUP] 1 [/SUP], Andrew J Barros[SUP] 2 [/SUP], Xiangyu Ye[SUP] 3 [/SUP], Haibo Zhang[SUP] 2 [/SUP], Qing Yu[SUP] 4 [/SUP], Samuel P Young[SUP] 5 [/SUP], Eric V Yeatts[SUP] 4 [/SUP], Yury Park[SUP] 4 [/SUP], Chaofan Li[SUP] 1 [/SUP], Sijie Hao[SUP] 6 [/SUP], Gislane Almeida-Santos[SUP] 1 [/SUP], Jinyi Tang[SUP] 1 [/SUP], Harish Narasimhan[SUP] 5 [/SUP], Nicole A Kirk[SUP] 7 [/SUP], Valeria Molinary[SUP] 8 [/SUP], Ying Li[SUP] 9 [/SUP], Li Li[SUP] 10 [/SUP], Bimal N Desai[SUP] 8 [/SUP], Peter Chen[SUP] 11 [/SUP], Kwon-Sik Park[SUP] 7 [/SUP], Anny Xiaobo Zhou[SUP] 12 [/SUP], Jeffrey M Sturek[SUP] 2 [/SUP], Wei Chen[SUP] 13 [/SUP], In Su Cheon[SUP] 1 [/SUP], Jie Sun[SUP] 14 [/SUP]


Affiliations
Abstract

The COVID-19 pandemic has highlighted the long-term consequences of viral pneumonia, yet its impact on cancer development remains unclear. Here, we show that patients previously hospitalized with severe COVID-19 have an increased risk of subsequent lung cancer. Across multiple murine models, severe respiratory viral infections accelerated lung cancer growth, whereas vaccination mitigated infection-enhanced tumor progression. Mechanistically, prior viral pneumonia reprogrammed the lung into a pro-tumor microenvironment marked by the sustained accumulation of tumor-associated neutrophils and heightened immunosuppression. We observed persistent chromatin remodeling at key cytokine loci in immune and structural cells, linking inflammatory memory to tumor-promoting signals. Therapeutically, combined blockade of neutrophil recruitment and programmed death-ligand 1 (PD-L1) restored CD8[SUP]+[/SUP] T cell function and suppressed tumor growth. Together, these findings establish a causal link between prior viral pneumonia and lung tumorigenesis, underscoring the need for enhanced surveillance and targeted interventions to reduce post-COVID cancer risk.

Keywords: COVID-19; epigenetic imprinting; influenza; lung cancer; respiratory viral infection; tumor-associated neutrophils.

 
Back
Top